Xylem Inc. (NYSE:XYL) Position Increased by LGT Group Foundation

LGT Group Foundation grew its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 36.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,966 shares of the industrial products company's stock after buying an additional 6,612 shares during the quarter. LGT Group Foundation's holdings in Xylem were worth $2,854,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Morgan Stanley raised its position in Xylem by 11.5% in the 3rd quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company's stock worth $412,267,000 after purchasing an additional 466,911 shares during the period. Invesco Ltd. grew its stake in Xylem by 35.1% in the 3rd quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company's stock worth $380,762,000 after acquiring an additional 1,086,102 shares in the last quarter. Royal Bank of Canada grew its stake in Xylem by 10.6% in the 3rd quarter. Royal Bank of Canada now owns 3,408,200 shares of the industrial products company's stock worth $310,249,000 after acquiring an additional 327,383 shares in the last quarter. Baillie Gifford & Co. grew its stake in Xylem by 2.3% in the 4th quarter. Baillie Gifford & Co. now owns 3,066,639 shares of the industrial products company's stock worth $350,701,000 after acquiring an additional 69,619 shares in the last quarter. Finally, Northern Trust Corp grew its stake in Xylem by 4.0% in the 3rd quarter. Northern Trust Corp now owns 2,617,441 shares of the industrial products company's stock worth $238,266,000 after acquiring an additional 100,728 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Stock Up 0.9 %

XYL traded up $1.22 during trading on Friday, hitting $137.21. The stock had a trading volume of 1,418,175 shares, compared to its average volume of 1,226,487. The company has a market capitalization of $33.26 billion, a PE ratio of 48.83, a PEG ratio of 2.67 and a beta of 1.08. Xylem Inc. has a twelve month low of $87.59 and a twelve month high of $138.46. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.30 and a current ratio of 1.67. The stock has a 50 day simple moving average of $128.64 and a two-hundred day simple moving average of $115.20.

Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.06. The company had revenue of $2.03 billion during the quarter, compared to the consensus estimate of $2 billion. Xylem had a net margin of 8.34% and a return on equity of 8.95%. Xylem's revenue was up 40.4% compared to the same quarter last year. During the same period last year, the firm earned $0.72 earnings per share. On average, research analysts predict that Xylem Inc. will post 4.2 earnings per share for the current year.

Xylem Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were issued a $0.36 dividend. The ex-dividend date was Tuesday, February 20th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.05%. This is a boost from Xylem's previous quarterly dividend of $0.33. Xylem's dividend payout ratio (DPR) is currently 51.25%.

Insiders Place Their Bets

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the transaction, the chief accounting officer now owns 2,935 shares of the company's stock, valued at $360,682.15. The transaction was disclosed in a filing with the SEC, which is available at this link. In related news, SVP Franz Cerwinka sold 2,408 shares of the firm's stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares of the company's stock, valued at $1,431,032.50. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares of the company's stock, valued at approximately $360,682.15. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Citigroup upped their target price on shares of Xylem from $126.00 to $139.00 and gave the stock a "neutral" rating in a research note on Monday, April 8th. BNP Paribas assumed coverage on shares of Xylem in a research note on Tuesday, March 12th. They issued an "outperform" rating and a $150.00 target price on the stock. Robert W. Baird upped their target price on shares of Xylem from $151.00 to $155.00 and gave the stock an "outperform" rating in a research note on Friday. Royal Bank of Canada increased their price objective on shares of Xylem from $157.00 to $162.00 and gave the company an "outperform" rating in a research note on Friday. Finally, Stifel Nicolaus increased their price objective on shares of Xylem from $136.00 to $150.00 and gave the company a "buy" rating in a research note on Wednesday, February 7th. Five equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $140.70.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.